Severe Sepsis-Associated Morbidity and Mortality among Critically Ill Children with Cancer

Abstract

Severe sepsis (SS) in pediatric oncology patients is a leading cause of morbidity and mortality. We investigated the incidence of and risk factors for morbidity and mortality among children diagnosed with cancer from 2008 to 2012, and admitted with SS during the 3 years following cancer diagnosis. A total of 1,002 children with cancer were included, 8% of whom required pediatric intensive care unit (PICU) admission with SS. Death and/or multiple organ dysfunction syndrome occurred in 34 out of 99 PICU encounters (34%). Lactate level and history of stem-cell transplantation were significantly associated with the development of death and/or organ dysfunction (p < 0.05).

Keywords

sepsis - septic shock - oncology - morbidity and mortality

• References

• 1 National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program Research Data (1973–2014). DCCPS, Surveillance Research Program, Surveillance Systems Branch. 2014. doi: http://www.seer.cancer.gov
• 2 Pritchard-Jones K, Kaatsch P, Steliarova-Foucher E, Stiller CA, Coebergh JW. Cancer in children and adolescents in Europe: developments over 20 years and future challenges. Eur J Cancer 2006; 42 (13) 2183-2190
• 3 Mertens AC, Yong J, Dietz AC. , et al. Conditional survival in pediatric malignancies: analysis of data from the Childhood Cancer Survivor Study and the Surveillance, Epidemiology, and End Results Program. Cancer 2015; 121 (07) 1108-1117
• 4 Phillips RS, Sutton AJ, Riley RD, Chisholm JC, Picton SV, Stewart LA. ; PICNICC Collaboration. Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol). Syst Rev 2012; 1: 8
• 5 Demaret P, Pettersen G, Hubert P, Teira P, Emeriaud G. The critically-ill pediatric hemato-oncology patient: epidemiology, management, and strategy of transfer to the pediatric intensive care unit. Ann Intensive Care 2012; 2 (01) 14
• 6 Haase R, Lieser U, Kramm C. , et al. Management of oncology patients admitted to the paediatric intensive care unit of a general children's hospital - a single center analysis. Klin Padiatr 2011; 223 (03) 142-146
• 7 Meyer S, Gottschling S, Biran T. , et al. Assessing the risk of mortality in paediatric cancer patients admitted to the paediatric intensive care unit: a novel risk score?. Eur J Pediatr 2005; 164 (09) 563-567
• 8 Zinter MS, DuBois SG, Spicer A, Matthay K, Sapru A. Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unit. Intensive Care Med 2014; 40 (10) 1536-1544
• 9 Singer K, Subbaiah P, Hutchinson R, Odetola F, Shanley TP. Clinical course of sepsis in children with acute leukemia admitted to the pediatric intensive care unit. Pediatr Crit Care Med 2011; 12 (06) 649-654
• 10 Russell HV, Okcu MF, Kamdar K. , et al. Algorithm for analysis of administrative pediatric cancer hospitalization data according to indication for admission. BMC Med Inform Decis Mak 2014; 14: 88
• 11 Turkoglu M, Mirza E, Tunçcan OG. , et al. Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: risk factors and impact on mortality. J Crit Care 2011; 26 (05) 460-467
• 12 Pound CM, Johnston DL, Armstrong R, Gaboury I, Menon K. The morbidity and mortality of pediatric oncology patients presenting to the intensive care unit with septic shock. Pediatr Blood Cancer 2008; 51 (05) 584-588
• 13 Hallahan AR, Shaw PJ, Rowell G, O'Connell A, Schell D, Gillis J. Improved outcomes of children with malignancy admitted to a pediatric intensive care unit. Crit Care Med 2000; 28 (11) 3718-3721
• 14 Fiser RT, West NK, Bush AJ, Sillos EM, Schmidt JE, Tamburro RF. Outcome of severe sepsis in pediatric oncology patients. Pediatr Crit Care Med 2005; 6 (05) 531-536
• 15 Kutko MC, Calarco MP, Flaherty MB. , et al. Mortality rates in pediatric septic shock with and without multiple organ system failure. Pediatr Crit Care Med 2003; 4 (03) 333-337
• 16 Weiss SL, Fitzgerald JC, Pappachan J. , et al; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med 2015; 191 (10) 1147-1157
• 17 Dervan LA, Watson RS. Incorporating morbidity into PICU quality measures: a “TOPICC” of critical importance. Crit Care Med 2015; 43 (08) 1781-1782
• 18 Farris RW, Weiss NS, Zimmerman JJ. Functional outcomes in pediatric severe sepsis: further analysis of the researching severe sepsis and organ dysfunction in children: a global perspective trial. Pediatr Crit Care Med 2013; 14 (09) 835-842
• 19 Lin JC, Spinella PC, Fitzgerald JC. , et al; Sepsis Prevalence, Outcomes, and Therapy Study Investigators. New or progressive multiple organ dysfunction syndrome in pediatric severe sepsis: a sepsis phenotype with higher morbidity and mortality. Pediatr Crit Care Med 2017; 18 (01) 8-16
• 20 Goldstein B, Giroir B, Randolph A. ; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6 (01) 2-8
• 21 Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M. Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest 1996; 109 (04) 1033-1037
• 22 Ammann RA, Laws HJ, Schrey D. , et al. Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors. Eur J Pediatr 2015; 174 (05) 675-686
• 23 Ammann RA, Bodmer N, Hirt A. , et al. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol 2010; 28 (12) 2008-2014
• 24 Rosolem MM, Rabello LS, Lisboa T. , et al. Critically ill patients with cancer and sepsis: clinical course and prognostic factors. J Crit Care 2012; 27 (03) 301-307
• 25 Viscoli C, Castagnola E, Giacchino M. , et al. Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section. Eur J Cancer 1999; 35 (05) 770-774
• 26 Tamburro R. Pediatric cancer patients in clinical trials of sepsis: factors that predispose to sepsis and stratify outcome. Pediatr Crit Care Med 2005; 6 (3, Suppl): S87-S91
• 27 Costa PdeO, Atta EH, Silva AR. Predictors of 7- and 30-day mortality in pediatric intensive care unit patients with cancer and hematologic malignancy infected with Gram-negative bacteria. Braz J Infect Dis 2014; 18 (06) 591-599
• 28 Workman JK, Ames SG, Reeder RW. , et al. Treatment of pediatric septic shock with the surviving sepsis campaign guidelines and PICU patient outcomes. Pediatr Crit Care Med 2016; 17 (10) e451-e458
• 29 Kapoor N. Graft-versus-host disease and immunosuppression. Immunol Res 2008; 41 (01) 34-44
• 30 Jat KR, Jhamb U, Gupta VK. Serum lactate levels as the predictor of outcome in pediatric septic shock. Indian J Crit Care Med 2011; 15 (02) 102-107
• 31 Bai Z, Zhu X, Li M. , et al. Effectiveness of predicting in-hospital mortality in critically ill children by assessing blood lactate levels at admission. BMC Pediatr 2014; 14: 83
• 32 Miedema KG, Tissing WJ, Abbink FC. , et al. Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study. Eur J Cancer 2016; 53: 16-24
• 33 Hakim H, Flynn PM, Srivastava DK. , et al. Risk prediction in pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J 2010; 29 (01) 53-59
• 34 Baorto EP, Aquino VM, Mullen CA, Buchanan GR, DeBaun MR. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer 2001; 92 (04) 909-913